Vor Bio price target lowered to $14 from $22 at Baird

Baird lowered the firm’s price target on Vor Bio (VOR) to $14 from $22 and keeps an Outperform rating on the shares. The firm said Vor announced 3Q24 financials and provided pipeline updates, which were generally in line with expectations ahead of key ASH data.